These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37583856)

  • 21. Combination of DNA-hypomethylating agent and hematopoietic stem cell transplantation in treatment of juvenile myelomonocytic leukemia: A case report.
    Ai Y; Lu X; Zhu T; Zhu Y; Liu H; Sun S
    Medicine (Baltimore); 2020 Dec; 99(50):e23606. PubMed ID: 33327329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X; Qing A; Ji P; French SW; Mason H
    Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement.
    Lin P; Jones D; Dorfman DM; Medeiros LJ
    Am J Surg Pathol; 2000 Nov; 24(11):1480-90. PubMed ID: 11075849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case report: A rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and MECOM mutations.
    Wang L; Tang J; Feng J; Huang Y; Cheng Y; Xu H; Miao Y
    Front Immunol; 2022; 13():1001482. PubMed ID: 36325357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia.
    Park H; Chung H; Lee J; Jang J; Kim Y; Kim SJ; Kim JS; Min YH; Cheong JW
    Yonsei Med J; 2017 Jan; 58(1):35-42. PubMed ID: 27873493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy.
    Srivastava P; Paluch BE; Matsuzaki J; James SR; Collamat-Lai G; Blagitko-Dorfs N; Ford LA; Naqash R; Lübbert M; Karpf AR; Nemeth MJ; Griffiths EA
    Oncotarget; 2016 Mar; 7(11):12840-56. PubMed ID: 26883197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based study.
    Zeidan AM; Hu X; Long JB; Wang R; Ma X; Podoltsev NA; Huntington SF; Gore SD; Davidoff AJ
    Cancer; 2017 Oct; 123(19):3754-3762. PubMed ID: 28621841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
    DiNardo CD; Maiti A; Rausch CR; Pemmaraju N; Naqvi K; Daver NG; Kadia TM; Borthakur G; Ohanian M; Alvarado Y; Issa GC; Montalban-Bravo G; Short NJ; Yilmaz M; Bose P; Jabbour EJ; Takahashi K; Burger JA; Garcia-Manero G; Jain N; Kornblau SM; Thompson PA; Estrov Z; Masarova L; Sasaki K; Verstovsek S; Ferrajoli A; Weirda WG; Wang SA; Konoplev S; Chen Z; Pierce SA; Ning J; Qiao W; Ravandi F; Andreeff M; Welch JS; Kantarjian HM; Konopleva MY
    Lancet Haematol; 2020 Oct; 7(10):e724-e736. PubMed ID: 32896301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort.
    Stahl M; DeVeaux M; Montesinos P; Itzykson R; Ritchie EK; Sekeres MA; Barnard JD; Podoltsev NA; Brunner AM; Komrokji RS; Bhatt VR; Al-Kali A; Cluzeau T; Santini V; Fathi AT; Roboz GJ; Fenaux P; Litzow MR; Perreault S; Kim TK; Prebet T; Vey N; Verma V; Germing U; Bergua JM; Serrano J; Gore SD; Zeidan AM
    Blood Adv; 2018 Apr; 2(8):923-932. PubMed ID: 29685952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy.
    Oh SB; Park SW; Chung JS; Lee WS; Lee HS; Cho SH; Choi YS; Lim SN; Shin HJ;
    Ann Hematol; 2017 Nov; 96(11):1801-1809. PubMed ID: 28828639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of treatment of lymphoblastic lymphoma at the children cancer hospital Egypt - A single center experience.
    Rahman Sayed HA; Sedky M; Hamoda A; Kinaaie NE; Wakeel ME; Hesham D
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):175-81. PubMed ID: 27339800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible cardiomyopathy in a patient with chronic myelomonocytic leukemia treated with decitabine/cedazuridine: a case report.
    Sheel A; Bae J; Asada A; Otterson GA; Baliga RR; Koenig KL
    Cardiooncology; 2023 Jan; 9(1):4. PubMed ID: 36653885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia.
    Santini V; Lübbert M; Wierzbowska A; Ossenkoppele GJ
    Adv Ther; 2022 Apr; 39(4):1474-1488. PubMed ID: 34786648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extramedullary tumors of lymphoid or myeloid blasts. The role of immunohistology in diagnosis and classification.
    Quintanilla-Martínez L; Zukerberg LR; Ferry JA; Harris NL
    Am J Clin Pathol; 1995 Oct; 104(4):431-43. PubMed ID: 7572794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precursor T-cell acute lymphoblastic leukemia presenting with bone marrow necrosis: a case report.
    Khoshnaw NS; Al-Rawi HA; Nore BF
    J Med Case Rep; 2012 Oct; 6():349. PubMed ID: 23057758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decitabine: An effective and safe treatment for myelodysplastic syndrome and acute myeloid leukemia.
    Feng X; Chen X; Nie S; Chang Y; Meng F; Zhou J; Mao C; Li T; Yan X; Huang J; Liu S; Gao Y; Xiao S
    J Cancer Res Ther; 2019; 15(7):1471-1476. PubMed ID: 31939424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Azacitidine and Decitabine in Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Network Meta-analysis.
    Liu W; Zhou Z; Chen L; Wang X
    Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e530-e544. PubMed ID: 33716056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature.
    Trimaldi J; Carballido EM; Bowers JW; Anguiano AL; Zhang ZJ; Shah BD; Bruno S; List AF; Moscinski LC; Grady T; Agosti SJ; Kang L; Zhang L
    Acta Haematol; 2013; 130(3):127-34. PubMed ID: 23594707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.